Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Koichiro Matsumura has a total of 244 co-authors. Here are the top co-authors by number of shared publications:

  • Gaku Nakazawa

    Division of Cardiology, Department of Medicine, Kindai University Faculty of Medicine

    23 shared publications
  • Masafumi Ueno

    Department of Cardiology, Kindai University Faculty of Medicine

    20 shared publications
  • Eijiro Yagi

    Department of Cardiology, Kindai University Faculty of Medicine

    18 shared publications
  • Ichiro Shiojima

    Division of Cardiology, Department of Medicine II, Kansai Medical University, Hirakata, Japan

    18 shared publications
  • Munemitsu Otagaki

    Division of Cardiology, Department of Medicine II, Kansai Medical University, Hirakata, Japan

    16 shared publications
  • Shohei Hakozaki

    Division of Cardiology, Department of Medicine, Kindai University Faculty of Medicine

    13 shared publications

Latest Publications

  • Open Access

    Early Vericiguat Initiation After First Hospitalization for Heart Failure With Reduced Ejection Fraction ― A Multicenter Observational Study From the VERIFY-HF Registry and Institutional Cohorts ―

    by Hiroki Matsuzoe, Koichiro Matsumura, Atsushi Suzuki, Ayano Yoshida, Shohei Hakozaki, Takahito Nasu, Wataru Fujimoto, Nobuyuki Kagiyama, Yasuyuki Shiraishi, Shunsuke Ishii, et al.

    Background: Hospitalization for the first episode of heart failure with reduced ejection fraction (HFrEF) represents an important opportunity to initiate evidence-based therapies. In this study, we aimed to clarify the role of vericiguat after first hospitalization for HFrEF in routine clinical practice.Methods and Results: This multicenter retrospective cohort study included patients with HFrEF at their first hospitalization between June 2021 and September 2023 identified from the nationwide Verifying Characteristics and Outcomes in Heart Failure Patients Treated with Vericiguat registry (vericiguat group, n=104) and 2 institutional databases (control group, n=206) (mean age, 67 years; 71% male). The primary endpoint was a composite of cardiovascular death or HF rehospitalization within 1 year. In inverse probability of treatment weighting-adjusted Cox models, vericiguat use was associated with a lower risk of the primary endpoint, compared with controls (hazard ratio, 0.26; 95% confidence interval, 0.08–0.81). Sensitivity analysis using alternative weighting methods and a doubly robust model yielded consistent results.Conclusions: In this real-world Japanese cohort of patients at first hospitalization for HFrEF, vericiguat initiation during index hospitalization was associated with a lower risk of cardiovascular death or HF rehospitalization after discharge. The observed association was directionally consistent with previous trials and pooled analyses, suggesting a potential benefit for this intermediate real-world population.

  • Open Access

    Impact of Nutritional Risk on Long-Term Prognosis in Older Patients With Stage B Heart Failure ― A PAPRIKA-HF Registry Subanalysis ―

    by Shohei Hakozaki, Koichiro Matsumura, Shun Morishita, Junko Morimoto, Satoshi Kurose, Kosuke Fujita, Takayuki Kawamura, Eijiro Yagi, Hiroki Matsuzoe, Masafumi Ueno, et al.

    Background: Malnutrition is a common geriatric syndrome associated with adverse long-term outcomes in hospitalized patients with heart failure (HF). However, its prognostic impact in outpatients with stage B HF remains unclear.Methods and Results: This multicenter, retrospective cohort study was conducted at 4 outpatient cardiology clinics between June 2021 and May 2023. Among 331 outpatients aged ≥65 years with stage B HF, 307 were included in the final analysis. Nutritional status was assessed using the Geriatric Nutritional Risk Index (GNRI). The primary endpoint was a composite of all-cause death or hospitalization for worsening HF during the 2-year follow-up period. The median GNRI was 102.8, and 22% (67/307) of patients were classified into the low-GNRI group (GNRI ≤ 98.0). Kaplan–Meier analysis showed that the low-GNRI group had a significantly higher incidence of the composite endpoint than the high-GNRI group (14.9% vs. 3.8%; log-rank P<0.001). In multivariable Cox proportional hazards models, a low GNRI was independently associated with adverse events (hazard ratio 3.41; 95% confidence interval 1.34–8.69; P=0.01).Conclusions: Low GNRI scores were independently associated with poorer long-term outcomes in older outpatients with stage B HF. Thus, the GNRI may serve as a simple and practical tool for early risk stratification of this population.

  • Open Access

    Association between current heated tobacco product use and incident hypertension: A nationwide real-world cohort study

    by Koichiro Matsumura, Takahiro Tabuchi, Hironori Imano, Shohei Hakozaki, Masafumi Ueno, Hidekazu Tanaka, Gaku Nakazawa

    : The cardiovascular effects of heated tobacco products (HTPs) remain controversial. Here, we investigated the association between smoking status, including current HTP use, and incident hypertension using a large Japanese real-world database. This study used the DeSC database, which integrates health check-up records, claims data, lifestyle questionnaires, and mHealth application information. Participants who completed a detailed smoking questionnaire between 2021 and 2025 and had no hypertension at baseline were included. Participants were classified into five groups: never-smokers, current HTP users, current cigarette smokers, dual users, and former smokers. Inverse probability of treatment weighting (IPTW) was applied to balance the baseline characteristics. The primary outcome was incident hypertension during follow-up, defined as elevated blood pressure measurements at follow-up or the initiation of antihypertensive medication. Among 30,979 participants (mean age, 46.8 ± 9.8 years; 37.0% female), incident hypertension occurred in 5.1% of never-smokers, 8.2% of current HTP users, 9.3% of current cigarette smokers, 8.2% of dual users, and 9.0% of former smokers. Compared with never-smokers, IPTW-weighted modified Poisson regression demonstrated significantly increased risks of hypertension among current HTP users (relative risk [RR], 1.23; 95% confidence interval [CI], 1.01–1.50), current cigarette smokers (RR, 1.28; 95% CI, 1.05–1.57), dual users (RR, 1.47; 95% CI, 1.08–2.01), and former smokers (RR, 1.17; 95% CI, 1.05–1.30). Current HTP users had a higher risk of incident hypertension than never-smokers. These findings demonstrate an association between current HTP use and incident hypertension but do not establish a causal effect of HTP exposure.

  • Open Access

    Association between physical activity and long-term prognosis in older patients with Stage B heart failure

    by Hiroyuki Tsukahara, Koichiro Matsumura, Shun Morishita, Junko Morimoto, Satoshi Kurose, Shohei Hakozaki, Eijiro Yagi, Masafumi Ueno, Hidekazu Tanaka, Yutaka Kimura, et al.

  • Open Access

    Left Ventricular Unloading With Impella Versus Intra‐Aortic Balloon Pump in Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation

    by Ryota Ito, Toru Kondo, Shingo Kazama, Takashi Araki, Takahiro Imaizumi, Takeru Nabeta, Yuki Ikeda, Hiroki Matsuzoe, Koichiro Matsumura, Koshiro Kanaoka, et al.

    Background: Optimal unloading strategies for patients with cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation remain uncertain, particularly when comparing Impella and intra‐aortic balloon pump (IABP). We aimed to compare outcomes of patients receiving Impella or IABP during venoarterial extracorporeal membrane oxygenation and evaluate cause‐specific differences. Methods: In this retrospective cohort study using the nationwide JROAD‐DPC (Japanese Registry of All Cardiac and Vascular Diseases–Diagnosis Procedure Combination) database from 2012 to 2023, patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation and either Impella or IABP were analyzed. Propensity score–based inverse probability of treatment weighting was applied to adjust baseline differences. Results: Among 18 906 patients (Impella, n=1688; IABP, n=17 218), overall in‐hospital mortality was 57.3% with Impella and 67.2% with IABP. Impella use was associated with lower in‐hospital mortality compared with IABP (odds ratio [OR], 0.86 [95% CI, 0.75–0.99]). Cause‐specific analyses showed significantly lower mortality with Impella in heart failure (OR, 0.66 [95% CI, 0.47–0.91]) and arrhythmia (OR, 0.62 [95% CI, 0.42–0.91]). Impella use was also associated with longer hospital stay (median, 22 versus 12 days), longer support duration (7 versus 4 days), and higher total costs (56.1 versus 27.3 thousand USD). Conclusions: In this nationwide cohort, Impella unloading during venoarterial extracorporeal membrane oxygenation was associated with lower in‐hospital mortality than IABP in the overall cohort, particularly in selected causes, at the expense of prolonged hospitalization and higher costs. Further studies are needed to define optimal cause‐specific unloading strategies in cardiogenic shock.

  • Relationship Between Social Frailty and Sarcopenia and Its Impact on Long‐Term Prognosis in Older Patients With Stage B Heart Failure: A PAPRIKA ‐ HF Registry Subanalysis

    by Shohei Hakozaki, Koichiro Matsumura, Shun Morishita, Junko Morimoto, Satoshi Kurose, Kazuyoshi Kakehi, Kosuke Fujita, Takayuki Kawamura, Eijiro Yagi, Hiroki Matsuzoe, et al.

    Aim: To investigate the association between social frailty and sarcopenia and their combined effect on clinical outcomes in outpatients with stage B heart failure (HF). Methods: This post hoc analysis of the PAPRIKA‐HF study included 331 patients aged ≥ 65 years with stage B HF. Patients were stratified into three groups based on social frailty and sarcopenia. The primary outcome was a 2‐year composite of all‐cause death, myocardial infarction, and HF hospitalization. Results: Of 308 patients, 189 (61%) had social frailty. Sarcopenia prevalence was higher in patients with versus without social frailty (20.6% vs. 11.8%, p = 0.04). Event rates for the composite outcome differed across groups (absence of social frailty and sarcopenia: 1.9% vs. presence of social frailty or sarcopenia: 3.0% vs. presence of both: 33.3%; log‐rank p < 0.001). In the multivariable Cox model, no significant difference existed between absence of social frailty and sarcopenia and presence of social frailty or sarcopenia (hazard ratio 2.44; 95% confidence interval 0.51–11.52; p = 0.26), while presence of both had higher risk compared with absence of both (hazard ratio 12.98; 95% confidence interval 2.46–68.50; p < 0.01). Conclusion: The coexistence of social frailty and sarcopenia is associated with adverse outcomes in outpatients with stage B HF. Early identification and multidisciplinary interventions for social frailty may help improve long‐term prognosis.


  • Open Access

    Psychological distress among family caregivers of patients with cardiovascular disease

    by Koichiro Matsumura, Eijiro Yagi, Yasuhiro Kakiuchi, Takahiro Tabuchi, Nobuhiro Yamada, Yohei Funauchi, Kazuyoshi Kakehi, Kosuke Fujita, Takayuki Kawamura, Hiroki Matsuzoe, et al.

    A BSTRACT: Background: Various studies have reported the clinical importance of psychological distress in patients with cardiovascular diseases (CVD). However, few studies have examined the psychological distress experienced by family caregivers of patients with CVD. This study aimed to examine how having to care for patients with CVD affects psychological distress among family members. Methods: Data on patients with CVD requiring care and family caregivers living with them were extracted from a nationwide population-based study in Japan (2019 Comprehensive Survey of Living Conditions), conducted by the Ministry of Health, Labor, and Welfare. Psychological distress was assessed using the Kessler Psychological Distress Scale-6 item score (0–24 points) from the questionnaire, and a score ≥9 was defined as psychological distress. Results: Family caregivers of patients with CVD who required care in 1990 were analyzed. The proportion of family caregivers experiencing psychological distress was 12.9% (257 in 1990). Multivariate logistic regression analysis revealed that the patients themselves had psychological distress, younger family caregivers, female family caregivers, family caregivers and patients residing alone, family caregivers who were not working, and patients with CVD complicated with dementia were independent factors affecting psychological distress in family caregivers. Conclusions: Multidisciplinary healthcare providers need to be aware of the mental health of not only patients with CVD requiring care but also their family caregivers and implement appropriate medical support.

  • Open Access

    Determinants and Prognostic Impact of In-Hospital Sodium-Glucose Cotransporter-2 Inhibitor Initiation in Patients with Heart Failure

    by Takuya Okamoto, Koichiro Matsumura, Shohei Hakozaki, Eijiro Yagi, Kazuyoshi Kakehi, Ayano Yoshida, Takayuki Kawamura, Kosuke Fujita, Masafumi Ueno, Kimiko Fujiwara, et al.

    Background and Objectives Initiation of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients hospitalised for heart failure (HF) is crucial for improving long-term outcomes. However, in real-world practice, a considerable proportion of patients are discharged without initiation. This study aimed to evaluate the initiation rate of SGLT2i, identify clinical factors associated with non-initiation, and examine the impact on long-term prognosis in patients hospitalised for HF. Methods This single-centre, retrospective, observational analysis of a prospective registry included 781 consecutive patients who were hospitalised for HF between 2021 and 2024. The primary endpoint was the in-hospital initiation rate of SGLT2i. Secondary endpoints included clinical factors associated with non-initiation, assessed using multivariable logistic regression, and the incidence of the composite endpoint of all-cause mortality or HF rehospitalisation at 1 year according to SGLT2i prescription status at discharge, evaluated by log-rank test and Cox proportional hazards analysis. Results A total of 467 patients (median age 81 [74–87] years, 50.3% male) were included in the final analysis. The initiation rate of SGLT2i during hospitalisation was 37.3% (174/467), and treatment discontinuation after initiation occurred in 8.6% (15/174). Multivariable analysis revealed that older age, non-diabetes, impaired renal function, higher left ventricular ejection fraction, malnutrition, impaired mobility, and cognitive dysfunction were independently associated with non-initiation. Among 346 patients with available follow-up data, the incidence of the composite endpoint at 1 year was significantly higher in the non-initiation group than in the initiation group (37.5% vs 21.3%, log-rank p = 0.001). In multivariable Cox analysis, not prescribed SGLT2i at discharge remained independently associated with worse long-term outcomes (hazard ratio 1.70, 95% confidence interval 1.07–2.69, p = 0.02). Conclusion Both conventional clinical factors (e.g., diabetes, left ventricular ejection fraction) and aging-related factors (e.g., nutritional status, mobility, cognitive function) were independently associated with non-initiation of SGLT2i in hospitalised patients with HF. Importantly, non-initiation at discharge was significantly associated with worse long-term outcomes, underscoring the need to promote active initiation of SGLT2i in this population.

  • Open Access

    Differential increase in peak oxygen uptake with cardiac rehabilitation among patients with stage B versus C heart failure

    by Eijiro Yagi, Koichiro Matsumura, Kensuke Takabayashi, Junko Morimoto, Takeshi Ijichi, Daiki Suzuki, Satoshi Kurose, Shota Asada, Shohei Hakozaki, Masafumi Ueno, et al.

    Article: Differential increase in peak oxygen uptake with cardiac rehabilitation among patients with stage B versus C heart failure - European Journal of Physical and Rehabilitation Medicine 2026 Feb 18 - Minerva Medica - Journals

  • Open Access

    Predicting Coronary Occlusion Risk during Redo‐TAVR at First TAVR: Asymmetric Calcification Causes Failure

    by Kyohei Onishi, Masakazu Yasuda, Nobuhiro Yamada, Naoko Soejima, Ayano Yoshida, Kosuke Fujita, Hiroki Matsuzoe, Tatsuya Miyoshi, Koichiro Matsumura, Kazuki Mizutani, et al.

    Background and Aims: Predicting coronary artery occlusion due to sinus sequestration (SS) during a second transcatheter aortic valve (TAV) procedure using pre‐procedural computed tomography (CT) after the first TAV replacement (TAVR) is underreported. This study aimed to investigate the accuracy of SS risk prediction using pre‐procedural CT by comparing it to the actual SS risk observed on post‐procedural CT during TAV‐in‐TAV. Methods and Results: We retrospectively evaluated 139 consecutive patients who underwent TAVR with a balloon‐expandable valve. The predicted valve‐to‐sinotubular junction (VTSTJ) length and calcium volume of each coronary cusp were measured on pre‐procedural CT. The observed VTSTJ length was assessed on post‐procedural CT. High SS risk was defined as VTSTJ < 2.0 mm in either the right or left coronary cusp. Pre‐procedural CT classified 78 patients into the high predicted SS (PSS) risk group; 77 (98.7%) showed a high observed SS (OSS) risk on post‐procedural CT. Among the 61 patients classified as having low PSS risk, 44 (72.1%) were found to have high OSS risk post‐TAVR. In this subgroup, patients with high OSS risk had a significantly higher proportion of non‐coronary cusp calcium volume (NCC‐CV) compared to those with low OSS risk (median 48.7% [interquartile range (IQR): 42.1–55.2] vs. 39.2% [IQR: 33.7–45.4]; p = 0.004). Multivariable logistic regression revealed NCC‐CV ≥ 41.6% as an independent predictor of high OSS risk during TAV‐in‐TAV (odds ratio: 12.59 [95% confidence interval: 4.20–44.14], p < 0.001). Conclusion: Asymmetric NCC calcification was associated with discrepancies in SS predictions on pre‐procedural CT.